Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment
NCT03515915
·
clinicaltrials.gov ↗
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Patients With Recurrent or Refractory Multiple Myeloma
Sponsor
University Hospital, Montpellier
Collaborators
[object Object]